Cited by 767Hormonal and reproductive studiesHypothalamic control of reproductive hormonesAdrenal Hormones and Disorders

Prevalence of hypogonadism in males aged at least 45 years: the HIM study

Open access
MULLIGAN, T., FRICK, M. F., ZURAW, Q. C., STEMHAGEN, A., MCWHIRTER, C.·2008·International Journal of Clinical Practice

Abstract

The Hypogonadism in Males study estimated the prevalence of hypogonadism [total testosterone (TT) < 300 ng/dl] in men aged > or = 45 years visiting primary care practices in the United States. A blood sample was obtained between 8 am and noon and assayed for TT, free testosterone (FT) and bioavailable testosterone (BAT). Common symptoms of hypogonadism, comorbid conditions, demographics and reason for visit were recorded. Of 2162 patients, 836 were hypogonadal, with 80 receiving testosterone. Crude prevalence rate of hypogonadism was 38.7%. Similar trends were observed for FT and BAT. Among men not receiving testosterone, 756 (36.3%) were hypogonadal; odds ratios for having hypogonadism were significantly higher in men with hypertension (1.84), hyperlipidaemia (1.47), diabetes (2.09), obesity (2.38), prostate disease (1.29) and asthma or chronic obstructive pulmonary disease (1.40) than in men without these conditions. The prevalence of hypogonadism was 38.7% in men aged > or = 45 years presenting to primary care offices.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1111/j.1742-1241.2006.00992.x

Cites

22 of 22 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Testosterone deficiency is highly prevalent, with rates increasing with age from 4% in men aged 40-49 years to nearly 50% in men over 80 years, and some studies suggest a 17% increase per decade of life.

    “Testosterone deficiency is highly prevalent, with rates increasing with age from 4% in men aged 40–49 years to nearly 50% in men over 80 years of age, with some studies suggesting a 17% increase in testosterone deficiency for every decade of life (2-4).”

    From Non-testosterone management of male hypogonadism: an examination of the existing literature (2020) · cites this paper as [4]

    The Results (page not available in our copy) report a 38.7% prevalence of hypogonadism among men aged at least 45 and a 17% increase in risk for each 10-year increase in age. The paper does not report the claimed age-specific rates of 4% at ages 40–49 or nearly 50% over age 80. (LLM, conf=0.88)

    Experimental — accuracy not yet measured

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

2 of the 24 references couldn’t be matched to a known paper.

Cited by

Sorted by citations

Authors
MULLIGAN, T., FRICK, M. F., ZURAW, Q. C., STEMHAGEN, A., & MCWHIRTER, C.
Affiliations
  • University of Florida (US)
  • Covance (United States) (US)
  • Solvay (United States) (US)
Corresponding author
MULLIGAN, T.
Venue
International Journal of Clinical Practice
Published
2008-10-09
Volume
60
Issue
7
Pages
762-769
ISSN
1368-5031 (ISSN-L)
OpenAlex
W1667402504
Cited by
767
References
24
Citations by year
2026: 14 · 2025: 37 · 2024: 37 · 2023: 32 · 2022: 35 · 2021: 42 · 2020: 44 · 2019: 38 · 2018: 34 · 2017: 54 · 2016: 60 · 2015: 40 · 2014: 58 · 2013: 60 · 2012: 42
FWCI
18.19
Type
journal article
Language
en
Open access
Locations
  • International Journal of Clinical Practice (publishedVersion)
  • PubMed (publishedVersion)
Topics
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Hormonal and reproductive studies
  • Health Sciences › Medicine › Reproductive Medicine › Hypothalamic control of reproductive hormones
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Adrenal Hormones and Disorders
Keywords
hypogonadism, androgen deficiency, prevalence, primary care, free testosterone, bioavailable testosterone, comorbidities, hypertension, hyperlipidemia, diabetes mellitus, obesity, prostate diseases, asthma, chronic obstructive pulmonary disease, testosterone replacement therapy
MeSH terms
Aged, Aged, 80 and over, Humans, Hypogonadism, Male, Middle Aged, Testosterone, United States, Prevalence

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review